Hostname: page-component-8448b6f56d-c4f8m Total loading time: 0 Render date: 2024-04-23T18:25:30.731Z Has data issue: false hasContentIssue false

Development of a biomarker for sucrose intake based on metabolomics

Published online by Cambridge University Press:  19 October 2012

A. M. Joosen
Affiliation:
Cranfield UniversityMK43 0AL
M. M. Clarke
Affiliation:
Cranfield UniversityMK43 0AL
J. K. Lodge
Affiliation:
Cranfield UniversityMK43 0AL Northumbria UniversityNE1 8ST
O. Mugridge
Affiliation:
MRC-Human Nutrition ResearchCB1 9NL
G. Frost
Affiliation:
Imperial College LondonSW7 2AZ
B. Engel
Affiliation:
University of SurreyGU2 7XH
K. Taillart
Affiliation:
Aberystwyth UniversitySY23 3FG, UK
A. J. Lloyd
Affiliation:
Aberystwyth UniversitySY23 3FG, UK
M. Beckmann
Affiliation:
Aberystwyth UniversitySY23 3FG, UK
J. Draper
Affiliation:
Aberystwyth UniversitySY23 3FG, UK
Rights & Permissions [Opens in a new window]

Abstract

Type
Abstract
Copyright
Copyright © The Authors 2012

Carbohydrates are the major source of energy in the diet and their intake is an important determinant of health. The intake of extrinsic sugars, such as sucrose, is of increasing public health concern as evidence suggests high intakes are associated with metabolic abnormalities leading to hyperlipidaemia, insulin resistance and increased risk of degenerative disease( Reference Malik, Popkin and Bray 1 ). It is important, therefore, to have an accurate determination of dietary sucrose intake and metabolomics has recently been shown to be a useful tool for measuring dietary exposure( Reference Lloyd, Fave and Beckmann 2 ). The aim of this study was to develop biomarkers of sucrose intake using metabolomics.

We performed a randomised, parallel, single-dose feeding study on 90 healthy females (aged 29.9±4.7 yr, BMI 23.3±2.5 kg/m2) consuming either 0 g, 50 g or 100 g sucrose in 500 ml water (30 subjects per group). Blood and urine samples were taken before and for 24 h post sucrose intake. Standard low carbohydrate meals were provided during the study period. Blood was analysed for markers of glucose control and lipid status, urine was measured for electrolytes and sucrose excretion. Urine and plasma samples underwent FIE-MS fingerprinting analysis using established protocols( Reference Fave, Beckmann and Lloyd 3 ), followed by GCMS and LCMS analysis.

FIE-MS fingerprinting analysis showed that the 3 h time point was the most informative in urine and plasma (PC-LDA Tw values>2) and out of 120 explanatory signals, highlighted 12 metabolite signals in urine and 23 metabolite signals in plasma above a statistical significance threshold (p<1×10−4) that were discriminatory and either positively or negatively correlated with sucrose intake over time. In urine, the main signals positively correlated with sucrose intake were attributed to sucrose at 3, 6 and 9 h, and fructose and erythronic acid at 3 h. In plasma erythronic acid was also discriminatory and several unknowns were also positively correlated with sucrose intake. In urine and/or plasma samples several discriminatory signals attributed to keto- and hydroxy acids, medium to long chain non-esterified fatty acids and derivatives (acyl-carnitines), indicative of a fasting response, were highly abundant following consumption of water and were generally negatively correlated with sucrose intake, certain species increasing with time in the 0 g group (e.g acetylcarnitine, 3-OH-butanoic acid). GCMS and LCMS profiling analysis of urine and/or plasma samples confirmed fingerprinting data in that sucrose, fructose and erythronic acid were the strongest dose responsive discriminators for sucrose intake and metabolites associated with a fasting response being negatively correlated with sucrose intake.

In conclusion, we have found sucrose, fructose, and erythronic acid to be positively correlated with sucrose intake suggesting that these could be developed further into quantitative biomarkers of sucrose intake. A fasting-to-fed metabolic switch was also evident over time indicating that total energy intake during the study was low.

This work was supported by the Food Standards Agency (N05084) and the Department of Health (024/0044). Any views expressed are the author's own.

References

1. Malik, VS, Popkin, BM, Bray, GA et al. (2010) Circulation 121, 1356–64.CrossRefGoogle Scholar
2. Lloyd, AJ, Fave, G, Beckmann, M et al. (2011) Am J Clin Nut 94, 981–91.CrossRefGoogle Scholar
3. Fave, G, Beckmann, M, Lloyd, AJ et al. (2011) Metabolomics 7, 469–84.CrossRefGoogle Scholar